Skip to main content
. 2021 Sep 6;13(17):4485. doi: 10.3390/cancers13174485

Figure 5.

Figure 5

(A) Picture of a human bone fibula sectioned into smaller pieces to fit 96-well flat-bottom plates. Relative growth viability (%) of A172 (B) U87-MG (C), and T98G (D) cells 72 h after 30 or 60 s CAP treatment with or without TMZ co-treatment. All of the cell lines were treated without media, and a bone section was placed on top of the wells. The treatment groups for each cell line were normalized to their relative untreated controls (0 s). A one-way ANOVA was performed with Tukey’s multiple comparison post hoc test. * p < 0.05; ** p < 0.01; *** p < 0.001; and **** p < 0.0001, ns—not significant vs. untreated control. n = 16.